Prevalence of Metabolic Syndrome and Its Components Among Korean Cancer Survivors

2.50
Hdl Handle:
http://hdl.handle.net/10755/621520
Category:
Full-text
Format:
Text-based Document
Type:
Poster
Level of Evidence:
N/A
Research Approach:
N/A
Title:
Prevalence of Metabolic Syndrome and Its Components Among Korean Cancer Survivors
Author(s):
Kim, Ji-Su; Kim, Kyunghee; Jang, Insil
Lead Author STTI Affiliation:
Lambda Alpha-at-Large
Author Details:
Ji-su Kim, PhD, RN, Professional Experience: 2014-present -- Assistant Professor, Department of Nursing, Chung-Ang University, Seoul, Republic of Korea 2010-2013 -- Assistant Professor, Department of Nursing,Hallym Polytechnic University, Chuncheon,Republic of Korea 2008-2010 -- Senior Researcher,KCDC,Korea National Health and Nutrition Survey, Seoul,Republic of Korea 2002-2005 -- RN, Chung-Ang University Hospital, Seoul,Republic of Korea Author Summary: I worked at Chung-Ang University Hospital from 2002 to 2005. In operating room, I acquired various clinical competence and research subjects. And then, I worked at Korea Center for Disease Control and Prevention from 2008 to 2010. I was a senior researcher and I performed the Korea National Health and Nutrition Examination Survey. And from 2010 to 2014, I taught the fundamental nursing at Hallym Polytechnic University. In present, I am working at Chung-Ang University.
Abstract:

Purpose: The 5-year survival rate of Korean cancer patients is continuously improving, and more than half of cancer patients are known to survive for more than 5 years. Recently, the cause of death in cancer survivors is often attributable to cardiovascular diseases resulting from factors related to metabolic syndrome rather than cancer relapse; therefore, the management of metabolic syndrome and its components is important to improve cancer survivorship. However, large variations in the prevalence of metabolic syndrome in cancer survivors have been reported depending on the study, and there is no guideline for management of metabolic syndrome in cancer patients yet. Furthermore, the number of studies on cancer survivors in Asian countries, including South Korea, is insufficient. This study aimed to identify differences in the prevalence of metabolic syndrome and its components depending on the cancer type, gender, and age group in Korean cancer survivors.

Methods: Data from the 2008–2012 Korean National Health and Nutrition Examination Survey (KNHANES)—a cross-sectional and nationally representative survey undertaken by the Korea Center for Disease Control and Prevention (KCDC)—were used. The KNHANES has a stratified multistage probability sampling design comprising health interviews, health behavior and nutrition survey, and health examination study. The SAS version 9.3 survey procedure (SAS Institute Inc., Cary NC, USA) used a complex sample design based on the survey data analysis; this provided sampling weights and nationally representative estimates. Differences in the ratios between the metabolic syndrome and its components by cancer type, gender, and age group were analyzed using chi-square tests.

Results: The results of the study are as follows. 1) Regarding the general characteristics of cancer survivors, 62.5% were female, the mean age was 57.7, 77.5% were urban residents, and 34.7% were elementary school graduates. As for economic status, 25.8% fell under the 2nd lowest quartile, and 44.4% were currently economically active. Among the cancer survivors, 7.4% were current smokers, 36.8% drank alcohol more than once a month, and 20.7% exercised regularly. Regarding cancer-related characteristics of cancer survivors, the mean age upon cancer diagnosis was 50.1, and 35.3% were currently undergoing treatment. In terms of the type of cancer diagnosed, gastric cancer accounted for 19.6%; thyroid cancer, 18.5%; cervical cancer, 13.8%; breast cancer, 12.40%; colorectal cancer, 10.3%; liver cancer, 2.77%; and lung cancer, 2.21%. 2) Based on the diagnostic criteria of the American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, the prevalence of metabolic syndrome was 46.9% in cervical cancer, 43.9% in colorectal cancer, 38.6% in lung cancer, and 35.9% in breast cancer. 3) Regarding gender, the prevalence of metabolic syndrome in female cancer survivors was 38.3%, which was significantly higher than that in male cancer survivors (30.4%) (p = 0.022). In the components of metabolic syndrome, there were differences depending on gender in waist circumference, low HDL-cholesterol, and high blood sugar. The rates of waist circumference obesity and high blood sugar were higher in female cancer survivors, while the rate of low HDL-cholesterol was higher in male cancer survivors. 4) In terms of age, the prevalence of metabolic syndrome was higher as age increased, and the difference was statistically significant (p<.001): 18.4% in the young adult group (20-39 years), 27.9% in the middle age group (40-59 years), and 46.1% in the old age group (60 years and older). In the components of metabolic syndrome, high triglyceride, low HDL-cholesterol, and high blood sugar differed depending on the age group; as age increased, the rates of high triglyceride, low HDL-cholesterol, and high blood sugar became higher.

Conclusion: In summary, the prevalence of metabolic syndrome in cancer survivors was approximately 10 to 20% higher than that in healthy Koreans. Particularly, the prevalence of metabolic syndrome was higher in female cancers, including cervical cancer and breast cancer, and in colorectal cancer. Moreover, the prevalence of metabolic syndrome was higher in females and in the old age group. Therefore, management of metabolic syndrome should be actively carried out for groups with a high prevalence of metabolic syndrome, and consideration should be given to components with a high risk of onset for each group when developing programs for metabolic syndrome in cancer survivors.

Keywords:
Cancer Survivor; Metabolic Syndrome; Oncology
Repository Posting Date:
19-Jun-2017
Date of Publication:
19-Jun-2017
Other Identifiers:
INRC17PST621
Conference Date:
2017
Conference Name:
28th International Nursing Research Congress
Conference Host:
Sigma Theta Tau International
Conference Location:
Dublin, Ireland
Sponsors:
This study was supported by the National Research Foundation of Korea (NRF) funding grant (NRF-2015R1C1A1A02036408).
Description:
Event Theme: Influencing Global Health Through the Advancement of Nursing Scholarship

Full metadata record

DC FieldValue Language
dc.language.isoen_USen
dc.type.categoryFull-texten
dc.formatText-based Documenten
dc.typePosteren
dc.evidence.levelN/Aen
dc.research.approachN/Aen
dc.titlePrevalence of Metabolic Syndrome and Its Components Among Korean Cancer Survivorsen_US
dc.contributor.authorKim, Ji-Suen
dc.contributor.authorKim, Kyungheeen
dc.contributor.authorJang, Insilen
dc.contributor.departmentLambda Alpha-at-Largeen
dc.author.detailsJi-su Kim, PhD, RN, Professional Experience: 2014-present -- Assistant Professor, Department of Nursing, Chung-Ang University, Seoul, Republic of Korea 2010-2013 -- Assistant Professor, Department of Nursing,Hallym Polytechnic University, Chuncheon,Republic of Korea 2008-2010 -- Senior Researcher,KCDC,Korea National Health and Nutrition Survey, Seoul,Republic of Korea 2002-2005 -- RN, Chung-Ang University Hospital, Seoul,Republic of Korea Author Summary: I worked at Chung-Ang University Hospital from 2002 to 2005. In operating room, I acquired various clinical competence and research subjects. And then, I worked at Korea Center for Disease Control and Prevention from 2008 to 2010. I was a senior researcher and I performed the Korea National Health and Nutrition Examination Survey. And from 2010 to 2014, I taught the fundamental nursing at Hallym Polytechnic University. In present, I am working at Chung-Ang University.en
dc.identifier.urihttp://hdl.handle.net/10755/621520-
dc.description.abstract<p><strong>Purpose: </strong><span>The 5-year survival rate of Korean cancer patients is continuously improving, and more than half of cancer patients are known to survive for more than 5 years. Recently, the cause of death in cancer survivors is often attributable to cardiovascular diseases resulting from factors related to metabolic syndrome rather than cancer relapse; therefore, the management of metabolic syndrome and its components is important to improve cancer survivorship. However, large variations in the prevalence of metabolic syndrome in cancer survivors have been reported depending on the study, and there is no guideline for management of metabolic syndrome in cancer patients yet. Furthermore, the number of studies on cancer survivors in Asian countries, including South Korea, is insufficient. This study aimed to identify differences in the prevalence of metabolic syndrome and its components depending on the cancer type, gender, and age group in Korean cancer survivors.</span></p> <p><strong>Methods: </strong>Data from the <strong>2008–2012 </strong>Korean National Health and Nutrition Examination Survey (KNHANES)—a cross-sectional and nationally representative survey undertaken by the Korea Center for Disease Control and Prevention (KCDC)—were used. The KNHANES has a stratified multistage probability sampling design comprising health interviews, health behavior and nutrition survey, and health examination study. The SAS version 9.3 survey procedure (SAS Institute Inc., Cary NC, USA) used a complex sample design based on the survey data analysis; this provided sampling weights and nationally representative estimates. Differences in the ratios between the metabolic syndrome and its components by cancer type, gender, and age group were analyzed using chi-square tests.</p> <p><strong>Results: </strong>The results of the study are as follows. 1) Regarding the general characteristics of cancer survivors, 62.5% were female, the mean age was 57.7, 77.5% were urban residents, and 34.7% were elementary school graduates. As for economic status, 25.8% fell under the 2<sup>nd </sup>lowest quartile, and 44.4% were currently economically active. Among the cancer survivors, 7.4% were current smokers, 36.8% drank alcohol more than once a month, and 20.7% exercised regularly. Regarding cancer-related characteristics of cancer survivors, the mean age upon cancer diagnosis was 50.1, and 35.3% were currently undergoing treatment. In terms of the type of cancer diagnosed, gastric cancer accounted for 19.6%; thyroid cancer, 18.5%; cervical cancer, 13.8%; breast cancer, 12.40%; colorectal cancer, 10.3%; liver cancer, 2.77%; and lung cancer, 2.21%. 2) Based on the diagnostic criteria of the American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, the prevalence of metabolic syndrome was 46.9% in cervical cancer, 43.9% in colorectal cancer, 38.6% in lung cancer, and 35.9% in breast cancer. 3) Regarding gender, the prevalence of metabolic syndrome in female cancer survivors was 38.3%, which was significantly higher than that in male cancer survivors (30.4%) (p = 0.022). In the components of metabolic syndrome, there were differences depending on gender in waist circumference, low HDL-cholesterol, and high blood sugar. The rates of waist circumference obesity and high blood sugar were higher in female cancer survivors, while the rate of low HDL-cholesterol was higher in male cancer survivors. 4) In terms of age, the prevalence of metabolic syndrome was higher as age increased, and the difference was statistically significant (p<.001): 18.4% in the young adult group (20-39 years), 27.9% in the middle age group (40-59 years), and 46.1% in the old age group (60 years and older). In the components of metabolic syndrome, high triglyceride, low HDL-cholesterol, and high blood sugar differed depending on the age group; as age increased, the rates of high triglyceride, low HDL-cholesterol, and high blood sugar became higher.</p> <p><span lang="EN-US"><strong>Conclusion: </strong>In summary, the prevalence of metabolic syndrome in cancer survivors was approximately 10 to 20% higher than that in healthy Koreans. Particularly, the prevalence of metabolic syndrome was higher in female cancers, including cervical cancer and breast cancer, and in colorectal cancer. Moreover, the prevalence of metabolic syndrome was higher in females and in the old age group. Therefore, management of metabolic syndrome should be actively carried out for groups with a high prevalence of metabolic syndrome, and consideration should be given to components with a high risk of onset for each group when developing programs for metabolic syndrome in cancer survivors.</span></p>en
dc.subjectCancer Survivoren
dc.subjectMetabolic Syndromeen
dc.subjectOncologyen
dc.date.available2017-06-19T14:37:54Z-
dc.date.issued2017-06-19-
dc.date.accessioned2017-06-19T14:37:54Z-
dc.conference.date2017en
dc.conference.name28th International Nursing Research Congressen
dc.conference.hostSigma Theta Tau Internationalen
dc.conference.locationDublin, Irelanden
dc.description.sponsorshipThis study was supported by the National Research Foundation of Korea (NRF) funding grant (NRF-2015R1C1A1A02036408).en
dc.descriptionEvent Theme: Influencing Global Health Through the Advancement of Nursing Scholarshipen
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.